Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
n-3 PUFAs for Prevention of Atrial Fibrillation Recurrence
NCT01198275Phase 3Completed
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Jan 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing n-3 PUFAs with Placebo (2 arms). Primary endpoint: Probability of Maintenance of Sinus Rhythm at One-year Follow up at 1 year. Started Jan 2006; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01198275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01198275.